Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Leflunomide therapy for adult...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

Bibliographic Details
Main Authors: Chenyang Zhao, Zhao Cui, Yimiao Zhang, Fang Wang, Xin Wang, Xuyang Cheng, Liqiang Meng, Gang Liu, Minghui Zhao, Yuanyuan Ji
Format: Article
Language:English
Published: Wolters Kluwer 2022-04-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001855
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/CM9.0000000000001855

Similar Items

  • Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features
    by: Xiaojie Gong, et al.
    Published: (2023-12-01)
  • Cyclosporine therapy in steroid-dependent or steroid-resistant idiopathic focal and segmental glomerulosclerosis
    by: Imen Gorsane, et al.
    Published: (2016-01-01)
  • Cyclosporine therapy in primary steroid-dependent and steroid-resistant focal segmental glomerulosclerosis in adults
    by: Nazarul Hassan Jafry, et al.
    Published: (2023-04-01)
  • Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?
    by: Andreas Kronbichler, et al.
    Published: (2014-01-01)
  • Pathogenesis of Focal Segmental Glomerulosclerosis
    by: Beom Jin Lim, et al.
    Published: (2016-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs